Results 281 to 290 of about 784,891 (338)

β‐Catenin localization in the ctenophore Mnemiopsis leidyi suggests an ancestral role in cell adhesion and nuclear function

Developmental Dynamics, EarlyView.
Abstract Background The emergence of multicellularity in animals marks a pivotal evolutionary event, which was likely enabled by molecular innovations in the way cells adhere and communicate with one another. β‐Catenin is significant to this transition due to its dual role as both a structural component in the cadherin–catenin complex and as a ...
Brian M. Walters, Lucas J. Guttieres, Mayline Goëb, Stanley J. Marjenberg, Mark Q. Martindale, Athula H. Wikramanayake   +5 more
wiley   +1 more source

Serum Low-Density Lipoprotein Cholesterol Levels are Associated with Relapse in Neuromyelitis Optica Spectrum Disorder. [PDF]

J Inflamm Res
Ding J, Chen FP, Song YY, Li HY, Ai XW, Chen Y, Han L, Zhou XJ, Zhu DS, Guan YT.   +9 more
europepmc   +1 more source

Unravelling the Mechanisms of Oxidised Low-Density Lipoprotein in Cardiovascular Health: Current Evidence from In Vitro and In Vivo Studies. [PDF]

Int J Mol Sci
Thangasparan S, Kamisah Y, Ugusman A, Mohamad Anuar NN, Ibrahim N'.   +4 more
europepmc   +1 more source

Additional role of low-density lipoprotein cholesterol on the risk of osteoporosis in men with or without coronary heart disease: a real-world longitudinal study. [PDF]

J Geriatr Cardiol
Zeng J, Pan ZM, Li T, Chen ZY, Cai XY, Gong ML, Deng XL, Wang SS, Li N, Liu M, Li CL.   +10 more
europepmc   +1 more source

Aggressive low-density lipoprotein (LDL) lowering for primary prevention: still an elusive goal. [PDF]

Lipids Health Dis
Sepehrinia M, Homayounfar R, Farjam M.
europepmc   +1 more source

Low-Density Lipoprotein Receptor Apolipoprotein B Gene Polymorphism in Kurdish Patients With Severe Hypercholesterolemia. [PDF]

Cureus
Sabri S, Salih S, Al-Timimi D.
europepmc   +1 more source

Correction to "Tumor-Activatable Nanoparticles Target Low-Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy". [PDF]

Adv Sci (Weinh)
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Electronegative low-density lipoprotein

Current Opinion in Lipidology, 2004
The occurrence in blood of an electronegatively charged LDL was described in 1988. During the 1990s reports studying electronegative LDL (LDL(-)) were scant and its atherogenic role controversial. Nevertheless, recent reports have provided new evidence on a putative atherogenic role of LDL(-).
Jordi Ordóñez-Llanos, José Luis Sánchez-Quesada, Sonia Benitez   +2 more
openaire   +3 more sources

Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol

Clinical Laboratory, 2017
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo Moriyama, Eiko Takahashi
openaire   +3 more sources

Low-density lipoprotein heterogeneity

Baillière's Clinical Endocrinology and Metabolism, 1995
As a key feature of the ALP, a raised level of small, dense LDL forms part of what is potentially the most common collection of lipoprotein abnormalities to influence the risk of CHD in the general population. The consistency of the association between a prevalence of small, dense LDL and increased risk of CHD is impressive, though the practical ...
openaire   +3 more sources